Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Southern California, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Southern California, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Southern California, Medical Devices Deals, 2011 to YTD 2017 10
University of Southern California, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Southern California, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 13
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Emulate Enters into Research Agreement with Lawrence J. Ellison Institute for Transformative Medicine of USC 15
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 16
Ventria Bioscience Enters Into Co-Development Agreement With University of Southern California 17
University of Southern California Forms Joint Venture With University Kidney Research Organization For Kidney Research Center 18
Licensing Agreements 19
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children’s Hospital 19
NextBio Enters Into Licensing Agreement With The University Of Southern California 20
Lotus Tissue Repair Enters Into Licensing Agreement With The University of Southern California 21
University of Southern California – Key Competitors 22
University of Southern California – Key Employees 23
University of Southern California – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Government and Public Interest 26
Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 26
Oct 26, 2017: TGen-USC study finds ‘Precision Medicine’ may not always be so precise 29
Oct 17, 2017: Schizophrenia disrupts the brain’s entire communication system 33
Sep 07, 2017: Researchers at USC Roski Eye Institute are First to Show LASIK Xtra Does Not Increase Corneal Stiffness Using Revolutionary Brillouin Microscopy Method to Measure Corneal Biomechanics 35
Apr 04, 2017: Drugs widely used in cancer therapy increase toxicity of chemotherapy in mice 37
Dec 13, 2016: Cholesterol-fighting drugs lower risk of Alzheimer’s disease 38
Jul 08, 2016: NIH Awards USC and CHLA $36.6 Million for Clinical and Translational Science 40
Jun 06, 2016: Scientists develop protein with potential to modify brain function, memory in mice and fish 41
May 12, 2016: $200 million gift launches Lawrence J. Ellison Institute for Transformative Medicine of USC 42
Apr 11, 2016: Newly Discovered Proteins May Protect Against Aging’s Illnesses 43
Mar 30, 2016: Early use of postmenopausal hormone therapy may prevent heart disease 44
Feb 25, 2016: USC Eye Institute researchers use Human Connectome Project brain mapping techniques to unlock mysteries that can lead to vision-restoring therapies 45
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
University of Southern California, Pharmaceuticals & Healthcare, Key Facts 2
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Southern California, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Southern California, Deals By Therapy Area, 2011 to YTD 2017 9
University of Southern California, Medical Devices Deals, 2011 to YTD 2017 10
University of Southern California, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 13
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Emulate Enters into Research Agreement with Lawrence J. Ellison Institute for Transformative Medicine of USC 15
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 16
Ventria Bioscience Enters Into Co-Development Agreement With University of Southern California 17
University of Southern California Forms Joint Venture With University Kidney Research Organization For Kidney Research Center 18
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 19
NextBio Enters Into Licensing Agreement With The University Of Southern California 20
Lotus Tissue Repair Enters Into Licensing Agreement With The University of Southern California 21
University of Southern California, Key Competitors 22
University of Southern California, Key Employees 23
University of Southern California, Subsidiaries 24
University of Southern California, Joint Venture 25
